Argenx
ARGX
#447
Rank
โ‚น4.764 T
Marketcap
โ‚น76,512
Share price
-3.89%
Change (1 day)
42.62%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

EPS for Argenx (ARGX)

EPS in 2025 (TTM): โ‚น776.72

According to Argenx 's latest financial reports the company's current EPS (TTM) is โ‚น804.31. In 2024 the company made an earnings per share (EPS) of โ‚น1,262 an increase over its 2023 EPS that were of -โ‚น467.90.

EPS history for Argenx from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)โ‚น776.72-38.47%
2024โ‚น1,262-369.77%
2023-โ‚น467.90-60.46%
2022-โ‚น1,18363.33%
2021-โ‚น724.52-40.37%
2020-โ‚น1,215183.47%
2019-โ‚น428.65123.09%
2018-โ‚น192.1454.93%
2017-โ‚น124.0214.07%
2016-โ‚น108.7213.05%
2015-โ‚น96.16-36.34%
2014-โ‚น151.06209.04%
2013-โ‚น48.88-33.99%
2012-โ‚น74.05185.59%
2011-โ‚น25.93